Autopsy report · NCT02290717

Fractional Laser in Combination With UVB Therapy in Vitiligo Patients

“Difficulty including patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Netherlands Institute for Pigment Disorders

Sponsor type

University, hospital or other

Conditions

Vitiligo

Interventions

Fractional CO2 laser; NB-UVB therapy; Fluticasone Propionate Cream 0.05%

Participants

0

Sites

1

Countries

Netherlands

Trials that died the same way

• Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis
  “Too much difficulties to includ patient” (79% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (76% match in meaning)
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
  “difficulty of enrolling patients” (74% match in meaning)
• Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
  “difficult to recruit patients” (74% match in meaning)
• Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics
  “Problems recruting patients” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.